4
Changes in Ownership
Dermata Therapeutics, Inc. Filed Acc 0000905718-21-001110
Director bought 35,714 shares
- Director acquired 278,291 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
HALE DAVID F · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-17 | Conversion : show line 1 in the form | +44,777 | 299,411 | I |
| 2021-08-17 | Conversion : show line 2 in the form | +12,195 | 311,606 | I |
| 2021-08-17 | Conversion : show line 3 in the form | +20,000 | 331,606 | I |
| 2021-08-17 | Conversion : show line 4 in the form | +174,216 | 505,822 | I |
| 2021-08-17 | Conversion : show line 5 in the form | +27,103 | 532,925 | I |
| 2021-08-17 | Purchase : show line 6 in the form | +35,714 | 35,714 | I |
| Open-market purchases · 35,714 sh | ||||
Table II: Derivative
8 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-17 | Conversion : show line 7 in the form Series 1d Preferred Stock | −302,112 | 0 | I |
| 2021-08-17 | Conversion : show line 8 in the form Series 1a Preferred Stock | −250,000 | 0 | I |
| 2021-08-17 | Conversion : show line 9 in the form Series 1b Preferred Stock | −410,000 | 0 | I |
| 2021-08-17 | Conversion : show line 10 in the form Series 1c Preferred Stock | −3,571,428 | 0 | I |
| 2021-08-17 | Conversion : show line 11 in the form Series 1 Preferred Stock | −555,622 | 0 | I |
| 2021-08-17 | Conversion : show line 12 in the form Series 1a Warrants | −62,500 | 0 | I |
| 2021-08-17 | Conversion : show line 13 in the form Warrant to Purchase Common Stock | +3,048 | 3,048 | I |
| 2021-08-17 | Purchase : show line 14 in the form Warrant to Purchase Common Stock | +35,714 | 35,714 | I |
Loading xslF345X03/dermata_fm4aug172021.xml…